CK-MB Immunoinhibition assay

For the quantitative in vitro determination of CK-MB in serum or plasma. This product is suitable for automated, semi-automated and manual use.

SKU: CK8026 Categories: , , Method: Immunoinhibition Format: Lyophilised Size: R1 4 x 20ml, R2 4 x 6ml Assay Range: Linear up to 2216 U/l Working Stability: To expiry at +2 to +8℃ Available Applications: Hitachi 917/Mod P Tags: , ,

$731.50

In stock

Quantity

- +

$731.50

In stock

Description

Description

Intended Use

For the quantitative in vitro determination of CK-MB in serum or plasma. This product is suitable for automated, semi-automated and manual use.

Clinical Significance

Creatine Kinase (CK) is internationally accepted as a sensitive and specific indicator of acute myocardial infarction (AMI). There are 3 iso-enzymes of CK, CK-MM, CK-MB and CK-BB. CK-BB is produced by the brain in very small insignificant amounts. CK-MM is produced by the skeletal and heart tissue and CK-MB is produced by the heart muscle. In the vast majority of cases the CK activity rises within 6 hours of an acute infarction. After about 20 hours maximum values are observed. The CK activity generally returns to normal between the fourth and fifth day post- infarction.

Available Applications

  • Hitachi 917/Mod P